Latest News
- Min. Nadda Unveils ?13,000-Crore Bio-Pharma SHAKTI and Chemical Parks Push to Expand India’s Global Chemicals and Biologics Footprint
- Aurobindo Pharma Subsidiary Launches Generic Cancer Drug in US, Expands Oncology Portfolio in Global Generics Market
- KIMS Hospitals Introduces Adaptive Deep Brain Stimulation in India for Advanced Parkinson’s Treatment
FAS sues Microlife AG for overcharging for blood pressure monitors
If found guilty of violating antitrust laws, the company could face a fine of up to 5 million rubles under the Russian Federation's Administrative Code.
Microlife AG, a Swiss manufacturer and supplier of blood pressure monitors, has been charged by Russia's Federal Antimonopoly Service (FAS). The FAS press service reported the news.
The complaint was filed after the Antimonopoly Service discovered that the manufacturing company was controlling retail prices for blood pressure monitors by establishing a minimum permitted price, which wholesale buyers were compelled to honour. The devices were then resold by wholesale buyers to pharmacies, marketplaces, and other retailers at prices that did not fall below the coordinated amount.
"As a consequence, competition between retailers had become non-existent. This resulted in the establishment and maintenance of fixed prices for blood pressure monitors," the press service stated.